Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Erythema, Fatigue, Herpes zoster, Myalgia, Pain
Clinical narrative: The worst SHINGLES ATTACK EVER HAD AND HAVE HAD SHINGRIX VACC./ Suspected vaccination failure; The worst SHINGLES ATTACK EVER HAD AND HAVE HAD SHINGRIX VACC.!; Heaviness; Burning in chest; Tingling; stabbing pain all over skin; red lesion on lower back; red lesion on lower back; light headedness; Fatigue; Fever; Muscle aches/pain; Joint pain; This case was reported by a consumer via other manufacturer and described the occurrence of suspected vaccination failure in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID 19 VACCINE PFIZER (batch number EK4176, expiry date unknown) and (batch number EJ1686, expiry date unknown) for prophylaxis, lisinopril and hydrochlorothiazide for drug use for unknown indication, montelukast for drug use for unknown indication and paracetamol (Tylenol) for drug use for unknown indication.   The patient's past medical history included spinal osteoarthritis, hips osteoarthritis and knee replacement (Bilateral). Previously administered products included Steroids injection. Concurrent medical conditions included allergy to antibiotic (Levaquin).   On an unknown date, the patient received Shingrix. On 9th February 2021, the patient received the 2nd dose of COVID 19 VACCINE PFIZER. On 19th January 2021, the 1st dose was an unknown dose. On an unknown date, the patient started lisinopril and hydrochlorothiazide at an unknown dose and frequency, montelukast at an unknown dose and frequency and Tylenol at an unknown dose and frequency. In February 2021, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, sensation of heaviness, chest burning, tingling, pain, erythema, skin lesion, light headedness, fatigue, fever, muscle pain and joint pain. The action taken with lisinopril and hydrochlorothiazide was unknown. The action taken with montelukast was unknown. The action taken with Tylenol was unknown. On an unknown date, the outcome of the vaccination failure, shingles, sensation of heaviness, chest burning, tingling, pain, erythema, skin lesion, light headedness, fatigue, fever, muscle pain and joint pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, sensation of heaviness, chest burning, tingling, pain, erythema, skin lesion, light headedness, fatigue, fever, muscle pain and joint pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient did not receive any other vaccine within 4 weeks prior to the Covid 19 vaccine. The patient received lisinopril hydrochlorothiazide, montelukast and Tylenol within 2 weeks of receiving Covid 19 vaccine. After receiving Shingrix vaccine and less than a week after receiving Covid 19 vaccine (Pfizer), the patient experienced heaviness, burning in chest, tingling, stabbing pain all over skin, red lesion on lower back, light headedness, fatigue, fever of 101 degree F, muscle aches/pain, joint pain and had the worst shingles attack ever. Treatment was not received for adverse events. Sine vaccination with Covid 19 vaccine the patient has not been tested for Covid 19. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown. It was unknown if the reporter considered the vaccination failure, shingles, sensation of heaviness, chest burning, tingling, pain, erythema, skin lesion, light headedness, fatigue, fever, muscle pain and joint pain to be related to Covid 19 vaccine, lisinopril hydrochlorothiazide, montelukast and Tylenol.